Skip to main content
. 2020 Nov 13;61(2):306–315. doi: 10.1016/j.ejvs.2020.10.025

Table 3.

Characteristics of vascular disease, presentation, treatment and general mortality of all patients referred to the Vascular Surgery Hubs in the Lombardy region, Italy, from 9 March to 28 April 2020 confirmed to be affected or non-affected by COVID on admission or during hospitalisation

Variable All patients (n = 305) COVID (n = 64) Non-COVID (n = 241) p
Vascular disease
 Acute limb ischaemia 97 (31.8) 41 (64.1) 56 (23.2) <.001
 Chronic limb ischaemia 71 (23.3) 12 (18.7) 59 (24.5) .41
 Limb necrosis/gangrene 29 (9.5) 3 (4.7) 26 (10.8) .16
 Aortic disease 45 (14.7) 1 (1.6) 44 (18.3) <.001
 Cerebrovascular disease 36 (11.8) 2 (3.1) 34 (14.1) .015
 Other 27 (8.9) 5 (7.8) 22 (9.1) 1.0
Patient presentation
 Coming from home 143 (46.9) 19 (29.7) 124 (51.4) .002
 Referred by another department 28 (9.2) 20 (31.2) 8 (3.3) <.001
 Referred by another hospital (Spoke) 88 (28.8) 19 (29.7) 69 (28.6) .88
 Referred by another hospital (non-Spoke) 46 (15.1) 6 (9.4) 40 (16.6) .17
Time from symptoms to treatment – h 50.8 ± 77.1 79.2 ± 103.7 28.2 ± 33.7 <.001
Pre-operative haemoglobin – g/dL 12.4 ± 2.3 12.5 ± 2.1 12.4 ± 2.3 .75
Pre-operative platelet count – ×109 241.6 ± 106.0 243.7 ± 88.6 240.9 ± 110.8 .85
Treatment
 Open surgery 158 (51.8) 36 (56.2) 122 (50.6) .48
 Endovascular surgery 70 (22.9) 6 (9.4) 64 (26.6) .003
 Hybrid surgery 39 (12.8) 10 (15.6) 29 (12.0) .53
 Primary major limb amputation 17 (5.6) 3 (4.7) 14 (5.8) 1.0
 Medical therapy 21 (6.9) 9 (14.1) 12 (5.0) .022
Global in hospital mortality 31 (10.2) 16 (25.0) 15 (6.2) <.001
 In patients undergoing surgery 23 (8.1) 11 (20.0) 12 (5.2) .001
 In patients treated medically 8 (38.1) 5 (55.5) 3 (25.0) .20

Data are presented as n (%) or mean ± standard deviation.

Parametric test (Student t-test) was used for comparison.